Redenlab ataxia experience

box-icon

Sites

40

box-icon

Patients

500

box-icon

Languages

14

box-icon

Clinical trials

10+

box-icon

Natural history studies

10+

    Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...
      Redenlab’s CEO, Adam Vogel, co-wrote "The Role of Verbal Fluency in the Cerebellar Cognitive Affective Syndrome Scale in Friedreich Ataxia"...
        Spinocerebellar ataxia Type 1 (SCA1) is a dominantly inherited neurodegenerative disease resulting in balance, speech, thinking and coordination difficulties. SCA1...

          Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research

            Functional magnetic resonance imaging (fMRI) offers valuable insights into how the brain controls motor speech functions. However, there are still...
              Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...